Jeff R. Schroeder

2014

In 2014, Jeff R. Schroeder earned a total compensation of $1.7M as Chief Commercial Officer at Oxford Immunotec Global, a 294% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$112,284
Option Awards$401,193
Salary$311,900
Stock Awards$839,595
Total$1,664,972

Schroeder received $839.6K in stock awards, accounting for 50% of the total pay in 2014.

Schroeder also received $112.3K in non-equity incentive plan, $401.2K in option awards and $311.9K in salary.

Rankings

In 2014, Jeff R. Schroeder's compensation ranked 5,315th out of 13,032 executives tracked by ExecPay. In other words, Schroeder earned more than 59.2% of executives.

ClassificationRankingPercentile
All
5,315
out of 13,032
59th
Division
Manufacturing
1,897
out of 4,966
62nd
Major group
Chemicals And Allied Products
636
out of 1,686
62nd
Industry group
Drugs
487
out of 1,365
64th
Industry
In Vitro and In Vivo Diagnostic Substances
18
out of 72
75th
Source: SEC filing on May 2, 2016.

Schroeder's colleagues

We found two more compensation records of executives who worked with Jeff R. Schroeder at Oxford Immunotec Global in 2014.

2014

Peter Wrighton-Smith

Oxford Immunotec Global

Chief Executive Officer

2014

Peter Edwardson

Oxford Immunotec Global

Chief Operations Officer

You may also like